Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response?^†‡

• Pages: 1671-1674
• First Published: 28 November 2007

Corticosteroid treatment in biliary atresia: Tonic or toast?^†‡

• Pages: 1675-1678
• First Published: 28 November 2007

Predicting prognosis in acute liver failure: Ammonia and the risk of cerebral edema^†‡

• Pages: 1679-1681
• First Published: 28 November 2007

MARS and the failing liver—Any help from the outer space?^†‡

• Pages: 1682-1684
• First Published: 28 November 2007

Therapy with vasoconstrictor drugs in cirrhosis: The time has arrived^†‡

• Pages: 1685-1687
• First Published: 28 November 2007

Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1–infected slow responders^†‡

• Pages: 1688-1694
• First Published: 28 November 2007

Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response^†

• Pages: 1695-1703
• First Published: 28 November 2007

Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection^†‡

• Pages: 1704-1712
• First Published: 28 November 2007

Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection^†

• Pages: 1713-1721
• First Published: 28 November 2007

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81^†

• Pages: 1722-1731
• First Published: 28 November 2007

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response^†‡

• Pages: 1732-1740
• First Published: 28 November 2007

Predictors of treatment in patients with chronic hepatitis C infection—Role of patient versus nonpatient factors^†

• Pages: 1741-1749
• First Published: 28 November 2007

Liver disease in adolescents: A cohort study of high-risk individuals^†‡

• Pages: 1750-1758
• First Published: 28 November 2007

Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycans^†

• Pages: 1759-1768
• First Published: 28 November 2007

Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice^†

• Pages: 1769-1778
• First Published: 28 November 2007

Fish oil prevents sucrose-induced fatty liver but exacerbates high-safflower oil-induced fatty liver in ddy mice^†

• Pages: 1779-1790
• First Published: 28 November 2007

Acute ethanol exposure inhibits insulin signaling in the liver^†

• Pages: 1791-1800
• First Published: 28 November 2007

Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins^†

• Pages: 1801-1809
• First Published: 28 November 2007

Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma^†

• Pages: 1810-1820
• First Published: 28 November 2007

Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia^†‡§

• Pages: 1821-1827
• First Published: 28 November 2007

The impact of ethnicity on the natural history of autoimmune hepatitis^†

• Pages: 1828-1835
• First Published: 28 November 2007

Quality of life and everyday activities in patients with primary biliary cirrhosis^†

• Pages: 1836-1843
• First Published: 28 November 2007

Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure^†

• Pages: 1844-1852
• First Published: 28 November 2007

Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis^†‡

• Pages: 1853-1862
• First Published: 28 November 2007

Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome^†

• Pages: 1863-1871
• First Published: 28 November 2007

Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure^†‡

• Pages: 1872-1882
• First Published: 28 November 2007

Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure^†‡

• Pages: 1883-1892
• First Published: 28 November 2007

High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats^†

• Pages: 1893-1906
• First Published: 28 November 2007

Minimizing risk associated with elderly liver donors by matching to preferred recipients^†

• Pages: 1907-1918
• First Published: 28 November 2007

Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats^†

• Pages: 1919-1926
• First Published: 28 November 2007

Effect of an oral iron chelator or iron-deficient diets on uroporphyria in a murine model of porphyria cutanea tarda^†

• Pages: 1927-1834
• First Published: 28 November 2007

Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep^†

• Pages: 1935-1945
• First Published: 28 November 2007

Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity^†

• Pages: 1946-1959
• First Published: 28 November 2007

Regulation of human liver δ-aminolevulinic acid synthase by bile acids^†

• Pages: 1960-1970
• First Published: 28 November 2007

Clonal, cultured, murine fetal liver hepatoblasts maintain liver specification in chimeric mice^†

• Pages: 1971-1978
• First Published: 28 November 2007

Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol^†

• Pages: 1979-1985
• First Published: 28 November 2007

Glucocorticoid-induced leucine zipper: A key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis^†

• Pages: 1986-1992
• First Published: 28 November 2007

Hepatocyte growth factor signaling pathway inhibits cholesterol 7α-hydroxylase and bile acid synthesis in human hepatocytes^†

• Pages: 1993-2002
• First Published: 28 November 2007

Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5^†

• Pages: 2003-2013
• First Published: 28 November 2007

Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations^†‡

• Pages: 2014-2020
• First Published: 28 November 2007

Dendritic cells, the liver, and transplantation^†

• Pages: 2021-2031
• First Published: 28 November 2007

Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease^†

• Pages: 2032-2039
• First Published: 28 November 2007

Hepatic Niemann-Pick C1–like 1: The canalicular side of the coin^†

• Pages: 2040-2042
• First Published: 28 November 2007

Identification of resident hepatic stem cell populations^†

• Pages: 2042-2044
• First Published: 28 November 2007

Effects of rosiglitazone on methionine-choline deficient diet-induced nonalcoholic steatohepatitis^†

• Page: 2045
• First Published: 28 November 2007

Reply:^†

• Pages: 2045-2046
• First Published: 28 November 2007

Coffee and hepatocellular carcinoma: Cause or confounding?^†

• Pages: 2046-2047
• First Published: 28 November 2007

Reply:^†

• Page: 2047
• First Published: 28 November 2007

Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers^†

• Pages: 2047-2048
• First Published: 28 November 2007

Reply:^†

• Page: 2048
• First Published: 28 November 2007

Hepatitis C virus kinetics in chimeric mice during antiviral therapy^†

• Pages: 2048-2049
• First Published: 28 November 2007

Hepatitis C virus RNA kinetics in chimeric mice with human hepatocytes during antiviral therapy^†

• Pages: 2049-2050
• First Published: 28 November 2007

Adipokines and insulin resistance in chronic hepatitis C^†

• Pages: 2050-2051
• First Published: 28 November 2007

Reply:^†

• Page: 2051
• First Published: 28 November 2007

• Page: 2052
• First Published: 28 November 2007

• Page: 2052
• First Published: 28 November 2007

• Page: 2052
• First Published: 28 November 2007